Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
03/2011
03/29/2011CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
03/29/2011CA2483752C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
03/24/2011WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression
03/24/2011US20110070192 Method of preparation of novel nucleoside analogs and uses
03/23/2011EP2298775A1 Diazabicyclic central nervous system active agents
03/23/2011EP2297166A1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
03/23/2011EP2144909B1 [2,6]naphthyridines useful as protein kinase inhibitors
03/23/2011CN101357917B Carbapenem compound containing formyl hydrazino
03/22/2011US7910728 Process for the preparation of a macrocycle
03/22/2011US7910601 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/22/2011US7910594 Antiproliferative agents; gene overexpression
03/22/2011US7910593 Water-soluble prodrugs
03/17/2011WO2011032050A2 Gyrase inhibitors
03/17/2011WO2011031818A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011WO2011031816A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011CA2773848A1 Pi3 kinase inhibitors and uses thereof
03/17/2011CA2772525A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011CA2772522A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/16/2011EP2295442A2 Inhibitors of interleukin-1beta converting enzyme
03/16/2011EP2295439A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
03/16/2011EP2295437A1 Diazabicyclic central nervous system active agents
03/16/2011EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors
03/16/2011EP2295434A2 Substituted 8-heteroaryl xanthines
03/16/2011EP2018388B1 Bisadenosine compounds as adenosine a2a receptor agonists
03/16/2011CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives
03/15/2011US7906039 Fluorescent diketopyrrolopyrroles
03/10/2011WO2011027081A2 Novel derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof
03/10/2011US20110059959 Novel multicyclic compounds and the use thereof
03/10/2011US20110059943 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
03/09/2011EP2292618A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/09/2011EP2292615A1 Quinazoline compounds
03/09/2011EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices
03/09/2011EP2024375B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/08/2011US7902203 Polymerase inhibitors; viricides; hepatitis c virus; immunology moderator; antiinflammatory agents; cirrhosis; liver disorders
03/08/2011US7902192 Inhibitors of P38 and methods of using the same
03/08/2011CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors
03/03/2011WO2011024976A1 Organic electroluminescent element
03/03/2011WO2011023883A1 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
03/03/2011CA2772102A1 Conjugates of pyrrolo[1,4] benzodiazepine dimers as anticancer agents
03/02/2011EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/02/2011EP1680481B1 New compound capable of being used in organic layer of organic light emitting device
03/01/2011US7897736 Fluorescent quenching detecting reagents and methods
03/01/2011US7897639 Amine group that, upon hydrolysis, becomes a component of a pharmacologically active agent for treatment of nervous system disordres
03/01/2011US7897635 HIV protease inhibitors
02/2011
02/24/2011WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition
02/24/2011WO2011021038A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
02/24/2011CA2771594A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
02/24/2011CA2771579A1 Nitrogen-containing compound and pharmaceutical composition
02/23/2011EP2286811A1 Chemokine receptor antagonists and methods of use thereof
02/23/2011CN101981039A Substituted heteroarylamide oxazepinopyrimidone derivatives
02/23/2011CN101981037A Pyrazolopyrimidine PI3K inhibitor compounds and methods of use
02/22/2011US7893280 2,4-disubstituted thiazolyl derivatives
02/22/2011CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/22/2011CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
02/22/2011CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors
02/17/2011US20110039838 Pyrrolotriazine compounds as kinase inhibitors
02/17/2011US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use
02/16/2011EP2284172A1 Immunomodulating heterocyclic compounds
02/16/2011EP2283021A2 Switchable special effect substances
02/16/2011EP1723151B1 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
02/15/2011US7888344 Fused thiazole derivatives as kinase inhibitors
02/15/2011US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase
02/15/2011CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/08/2011CA2459374C Photoactivable nitrogen bases
02/03/2011WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/03/2011WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/03/2011US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
02/03/2011CA2768527A1 Compounds - 801
02/03/2011CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/01/2011US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound
02/01/2011CA2494091C Substituted furo [2,3-b| pyridine derivatives
02/01/2011CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11
02/01/2011CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure
01/2011
01/27/2011WO2010130424A9 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
01/26/2011EP2276766A1 Tricyclic antibiotics
01/26/2011CN1726603B Charge transport compositions and electronic devices made with such compositions
01/26/2011CN101508697B Preparation method for vinorelbine
01/25/2011US7875713 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof
01/25/2011CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof
01/19/2011EP2274289A1 Electroluminescent materials
01/19/2011EP2274281A1 Hcv protease inhibitors
01/19/2011CN1976930B 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
01/19/2011CN101952295A Pyrrolopyrazine kinase inhibitors
01/19/2011CN101952286A Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
01/19/2011CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
01/18/2011US7872017 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease
01/18/2011US7871997 Potency against gram-positive bacteria, methicillin-resistant Staphylococci aureus (MRSA), methicillin-resistant Staphylococci epidermitis (MRSE).
01/18/2011CA2564201C Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
01/13/2011WO2011006143A2 Compounds and compositions for the treatment of parasitic diseases
01/13/2011WO2011006074A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
01/13/2011WO2011004610A1 Azabicyclo compound and salt thereof
01/13/2011US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/13/2011CA2767664A1 Compounds and compositions for the treatment of parasitic diseases
01/13/2011CA2767648A1 Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
01/13/2011CA2767556A1 Azabicyclo compound and salt thereof
01/12/2011EP2271647A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof
01/12/2011CN1950371B Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
01/12/2011CN101945877A Pyrrolopyrazine kinase inhibitors
01/12/2011CN101945874A 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents
01/12/2011CN101944571A Single-layer organic el device
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 111